← Open Payments lookup

PAUL HONGO: Open Payments

NPI 1598004954 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,734 in 85 payments from 18 companies in 2025. Trend: 2023 $1,673 · 2024 $1,317 · 2025 $1,734

Food & beverage: $1,734
CompanyPaymentsAmount
Gilead Sciences, Inc.20$537
ABBVIE INC.26$396
ViiV Healthcare Company10$215
Otsuka America Pharmaceutical, Inc.5$101
Lilly USA, LLC4$76
Merck Sharp & Dohme LLC2$60
AstraZeneca Pharmaceuticals LP3$50
Aimmune Therapeutics, Inc.3$47
Vanda Pharmaceuticals Inc.2$46
Axsome Therapeutics, Inc.2$44

Products named: VRAYLAR, QULIPTA, REXULTI, APRETUDE, CABENUVA, Biktarvy, PIFELTRO, KISUNLA.

Industry payments across CO — which companies pay providers there.